Logo image of AFX.DE

CARL ZEISS MEDITEC AG - BR (AFX.DE) Stock Price, Forecast & Analysis

Europe - Frankfurt Stock Exchange - FRA:AFX - DE0005313704 - Common Stock

39.44 EUR
-0.22 (-0.55%)
Last: 1/16/2026, 7:00:00 PM

AFX.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap3.53B
Revenue(TTM)2.23B
Net Income(TTM)141.22M
Shares89.44M
Float34.64M
52 Week High71.65
52 Week Low38.62
Yearly Dividend0.6
Dividend Yield1.39%
EPS(TTM)1.61
PE24.5
Fwd PE19.68
Earnings (Next)02-10
IPO2000-03-20
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
AFX.DE short term performance overview.The bars show the price performance of AFX.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20

AFX.DE long term performance overview.The bars show the price performance of AFX.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of AFX.DE is 39.44 EUR. In the past month the price decreased by -2.81%. In the past year, price decreased by -18.24%.

CARL ZEISS MEDITEC AG - BR / AFX Daily stock chart

AFX.DE Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

AFX.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to AFX.DE. AFX.DE is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AFX.DE Financial Highlights

Over the last trailing twelve months AFX.DE reported a non-GAAP Earnings per Share(EPS) of 1.61. The EPS decreased by -19.9% compared to the year before.


Industry RankSector Rank
PM (TTM) 6.34%
ROA 4.15%
ROE 6.67%
Debt/Equity 0.27
Chartmill High Growth Momentum
EPS Q2Q%-14.49%
Sales Q2Q%8.27%
EPS 1Y (TTM)-19.9%
Revenue 1Y (TTM)7.82%

AFX.DE Forecast & Estimates

22 analysts have analysed AFX.DE and the average price target is 49.78 EUR. This implies a price increase of 26.21% is expected in the next year compared to the current price of 39.44.

For the next year, analysts expect an EPS growth of 24.48% and a revenue growth 4.23% for AFX.DE


Analysts
Analysts71.82
Price Target49.78 (26.22%)
EPS Next Y24.48%
Revenue Next Year4.23%

AFX.DE Ownership

Ownership
Inst Owners25.21%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

AFX.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
2M6.DE MEDTRONIC PLC 17.35 107.89B
1SHL.MI SIEMENS HEALTHINEERS AG 19.62 52.88B
SHL.DE SIEMENS HEALTHINEERS AG 19.37 52.23B
PHI1.DE KONINKLIJKE PHILIPS NV 17.34 24.72B
PHIA.AS KONINKLIJKE PHILIPS NV 17.32 24.69B
1PHIA.MI KONINKLIJKE PHILIPS NV 17.36 24.74B
BIM.PA BIOMERIEUX 27.1 12.38B
OBCK.DE OTTOBOCK SE & CO KGAA 142.55 4.29B
DIA.MI DIASORIN SPA 22.54 4.17B
DRW3.DE DRAEGERWERK AG - PREF 13.62 1.65B
DRW8.DE DRAEGERWERK AG 10.7 1.29B
ELN.MI EL.EN. SPA 22.41 1.15B

Related stock screener links

About AFX.DE

Company Profile

AFX logo image Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.

Company Info

CARL ZEISS MEDITEC AG - BR

Goeschwitzer Strasse 51-52

Jena THUERINGEN DE

Employees: 5730

AFX Company Website

AFX Investor Relations

Phone: 493641220331

CARL ZEISS MEDITEC AG - BR / AFX.DE FAQ

What does AFX do?

Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.


What is the stock price of CARL ZEISS MEDITEC AG - BR today?

The current stock price of AFX.DE is 39.44 EUR. The price decreased by -0.55% in the last trading session.


What is the dividend status of CARL ZEISS MEDITEC AG - BR?

CARL ZEISS MEDITEC AG - BR (AFX.DE) has a dividend yield of 1.39%. The yearly dividend amount is currently 0.6.


What is the ChartMill rating of CARL ZEISS MEDITEC AG - BR stock?

AFX.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Would investing in CARL ZEISS MEDITEC AG - BR be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AFX.DE.


What is CARL ZEISS MEDITEC AG - BR worth?

CARL ZEISS MEDITEC AG - BR (AFX.DE) has a market capitalization of 3.53B EUR. This makes AFX.DE a Mid Cap stock.